| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.7326/0003-4819-151-8-200910200-00145 |
| P698 | PubMed publication ID | 19755348 |
| P50 | author | Thomas Trikalinos | Q60056375 |
| Teruhiko Terasawa | Q90201755 | ||
| Gowri Raman | Q90319547 | ||
| Joseph Lau | Q107974859 | ||
| P2093 | author name string | Stanley Ip | |
| Tomas Dvorak | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 556-565 | |
| P577 | publication date | 2009-09-14 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Systematic review: charged-particle radiation therapy for cancer | |
| P478 | volume | 151 |
| Q26767255 | A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments |
| Q55280639 | Advances in radiotherapy for esophageal cancer. |
| Q38693496 | An exploration of crowdsourcing citation screening for systematic reviews. |
| Q89816246 | Apoptosis and expression of apoptosis-related genes in mouse intestinal tissue after whole-body proton exposure |
| Q33914324 | Assessing the risk of second malignancies after modern radiotherapy |
| Q36175270 | Biological Effectiveness of Accelerated Protons for Chromosome Exchanges |
| Q39216032 | Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy |
| Q38339108 | Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience |
| Q92460404 | Characterization of the Mixed Radiation Field Produced by Carbon and Oxygen Ion Beams of Therapeutic Energy: A Monte Carlo Simulation Study |
| Q38108208 | Charged particle therapy--optimization, challenges and future directions |
| Q43379663 | Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience. |
| Q35620609 | Cost-effectiveness of proton beam therapy for intraocular melanoma |
| Q49264304 | Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. |
| Q39959382 | Fundus image fusion in EYEPLAN software: An evaluation of a novel technique for ocular melanoma radiation treatment planning |
| Q47160539 | INSIDE in-beam positron emission tomography system for particle range monitoring in hadrontherapy |
| Q34268907 | Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer |
| Q36140458 | Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. |
| Q38990272 | Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer |
| Q92969050 | Management of radiation-induced proctitis |
| Q28829311 | Mechanisms and Consequences of Double-Strand DNA Break Formation in Chromatin |
| Q45300344 | Nanoparticle-Mediated X-Ray Radiation Enhancement for Cancer Therapy |
| Q38520010 | Opportunities and challenges in using studies without a control group in comparative effectiveness reviews |
| Q38138821 | Position statement on ethics, equipoise and research on charged particle radiation therapy |
| Q90752608 | Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol |
| Q37582515 | Proton beam therapy and concurrent chemotherapy for esophageal cancer |
| Q37773102 | Proton therapy for cancer treatment |
| Q54968869 | Proton therapy for thoracic reirradiation of non-small cell lung cancer. |
| Q37026245 | Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma |
| Q36109855 | Protons sensitize epithelial cells to mesenchymal transition |
| Q39448990 | Radiation proctitis: current strategies in management |
| Q43084076 | Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). |
| Q38039264 | Real-time tumour tracking in particle therapy: technological developments and future perspectives. |
| Q35998340 | Relative Biological Effectiveness of HZE Particles for Chromosomal Exchanges and Other Surrogate Cancer Risk Endpoints |
| Q38210529 | Response to 'Position statement on ethics, equipoise and research on charged particle therapy'. |
| Q91714040 | Selection of Appropriate Wound Dressing for Various Wounds |
| Q24288974 | Semi-automated screening of biomedical citations for systematic reviews |
| Q36710649 | Standardized treatment planning methodology for passively scattered proton craniospinal irradiation |
| Q37129548 | The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic review |
| Q35531022 | The physics of proton therapy |
Search more.